View Single Post
Old 03-02-2009, 12:00 PM
lady_express_44's Avatar
lady_express_44 lady_express_44 is offline
Grand Magnate
 
Join Date: Aug 2006
Location: Vancouver, Canada
Posts: 3,300
15 yr Member
lady_express_44 lady_express_44 is offline
Grand Magnate
lady_express_44's Avatar
 
Join Date: Aug 2006
Location: Vancouver, Canada
Posts: 3,300
15 yr Member
Default

Quote:
Originally Posted by Riverwild View Post
Hey everyone! Hope y'all are doing well!
I missed # 24 Thursday after holding a perfect record up to now.

With all the stuff I have going on, the doc and I decided that I'll get # 24 at some point in the next few weeks after we are sure all the bugs are clear from the ruptured appendix.

I'm on heavy duty antibiotics and other meds and since there is no precedent for some of what I have done in the past week or so, we don't want to add any more problems to the mix!
Glad to see you up and about postinig, RW.

I was reading the information submitted for the upcoming AAN meeting scheduled for April/09, and noticed a topic called:

"Natalizumab Therapy, Surgery and Post-Operative Infectious Complications"
[P02.134], Tuesday, April 28, 2009 11:30 AM
Mark Gudesblatt, Myassar Zarif, Barbara Bumstead, Joshua Loewenstein, Anne Dunne, Lori Fafard, Laura Graffitti, Carol Seidel, Lourdes Cruz, Chris Burke, Serina Fahie, Joan Bohuslaw, Patchogue, NY

The conclusion of the study, which included 20 people who had one (or more!) surgeries over the 2 yrs, was:

"No MS patient receiving Natalizumab who underwent surgical treatment had any postoperative infectious complications. No patient required or experienced interruption in treatment. Surgery can be safely performed in MS patients receiving Natalizumab".

Hopefully that means you can back on track fairly quickly.

Cherie
__________________
I am not a Neurologist, Physician, Nurse, or Hairdresser ... but I have learned that it is not such a great idea to give oneself a haircut after three margaritas
.
lady_express_44 is offline  
"Thanks for this!" says:
Riverwild (03-02-2009)